SU 5214 (Synonyms: SU4949) |
| Katalog-Nr.GC40755 |
SU 5214 ist ein potenter VEGFR2-Inhibitor, extrahiert aus dem Patent US5834504A, SU 5214, hat IC50-Werte von 14,8 µM (FLK-1) bzw. 36,7 µM (EGFR).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 186611-04-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SU 5214 is a 3-heteroaryl-2-indoline that was designed in a drug discovery program for development of tyrosine kinase inhibitors.
Review for SU 5214
Average Rating: 5 (Based on Reviews and 37 reference(s) in Google Scholar.)
Review for SU 5214
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *